Pharmacological inhibition of Vanin-1 is not protective in models of acute and chronic kidney disease.

Saved in:
Bibliographic Details
Title: Pharmacological inhibition of Vanin-1 is not protective in models of acute and chronic kidney disease.
Authors: Unterschemmann K; Research and Early Development, Bayer Pharmaceuticals, Wuppertal, Germany., Ehrmann A; Drug Discovery Sciences, Bayer Pharmaceuticals, Wuppertal, Germany., Herzig I; Drug Discovery Sciences, Bayer Pharmaceuticals, Wuppertal, Germany., Andreevski AL; Research and Early Development, Bayer Pharmaceuticals, Wuppertal, Germany., Lustig K; Research and Early Development, Bayer Pharmaceuticals, Wuppertal, Germany., Schmeck C; Drug Discovery Sciences, Bayer Pharmaceuticals, Wuppertal, Germany., Eitner F; Research and Early Development, Bayer Pharmaceuticals, Wuppertal, Germany., Grundmann M; Research and Early Development, Bayer Pharmaceuticals, Wuppertal, Germany.
Source: American journal of physiology. Renal physiology [Am J Physiol Renal Physiol] 2021 Jan 01; Vol. 320 (1), pp. F61-F73. Date of Electronic Publication: 2020 Nov 16.
Publication Type: Journal Article
Journal Info: Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901990 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-1466 (Electronic) Linking ISSN: 15221466 NLM ISO Abbreviation: Am J Physiol Renal Physiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1522-1466
DOI:10.1152/ajprenal.00373.2020